Answer
Evolocumab (Repatha) should not be used during pregnancy unless the woman's clinical condition requires treatment with evolocumab, because data on its use in pregnant women are absent or limited.
Sources for this answer
- Repatha SureClickAmgen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 21Document updated
Sources checked